Table 4.

Difference-in-difference estimates of the effect of project POINT on patient outcomes.

	MOUD linkagea (N = 1462)	Non-MOUD opioid prescriptionsa (N = 1462)	Naloxone accessa (N = 1462)	Drug poisoningb (N = 1462)
Marginal effect of POINT	1.53***	1.00***	2.35***	0.14
	[0.21]	[0.11]	[0.51]	[0.78]
Incident-rate-ratios	5.29***	2.65***	10.38***
p-value	<0.001	<0.001	<0.001	0.856

Notes: Calculation based on INPC data January 1, 2012- July 6, 2019; unit of observation is the individual patient; all event-study regression estimates control for individual fixed effects, fixed effect for the period in which POINT was in effect (after February 2016), demographic controls and patient-level exposure to treatment, proxied by duration of the pre- and post- period for each patient. Estimates presented are marginal effects, standard errors are presented in parenthesis;

^amodeled using individual fixed-effect negative binomial regression;

^bmodeled using a fixed-effect logistic regression.